Search Results | Diabetes Care | American Diabetes Association

1-20 of 73

2 3 4

Sort by

Sort Order Select

Journal Articles

Safety and Efficacy of the Omnipod 5 Automated Insulin Delivery System in Adults With Type 2 Diabetes: From Injections to Hybrid Closed-Loop Therapy

Georgia M. Davis, Anne L. Peters, Bruce W. Bode, Anders L. Carlson, Bonnie Dumais, Todd E. Vienneau, Lauren M. Huyett, Trang T. Ly

Diabetes Care 2023;46(4):742–750

DOI: https://doi.org/10.2337/dc22-1915

Published: 14 February 2023

View article

Journal Articles

Quantifying the Relationship Between Physical Activity Energy Expenditure and Incident Type 2 Diabetes: A Prospective Cohort Study of Device-Measured Activity in 90,096 Adults

Tessa Strain, Paddy C. Dempsey, Katrien Wijndaele, Stephen J. Sharp, Nicola Kerrison, Tomas I. Gonzales, Chunxiao Li, Eleanor Wheeler, Claudia Langenberg, Søren Brage, Nick Wareham

Diabetes Care dc221467

DOI: https://doi.org/10.2337/dc22-1467

Published: 24 January 2023

View article

Journal Articles

7. Diabetes Technology: Standards of Care in Diabetes—2023

Diabetes Care 2023;46(Supplement_1):S111–S127

DOI: https://doi.org/10.2337/dc23-S007

Published: 12 December 2022

View article

Journal Articles

Index

Diabetes Care 2023;46(Supplement_1):S285–S291

DOI: https://doi.org/10.2337/dc23-in01

Published: 12 December 2022

View article

Journal Articles

Automated Insulin Delivery: Benefits, Challenges, and Recommendations. A Consensus Report of the Joint Diabetes Technology Working Group of the European Association for the Study of Diabetes and the American Diabetes Association

Jennifer L. Sherr, Lutz Heinemann, G. Alexander Fleming, Richard M. Bergenstal, Daniela Bruttomesso, Hélène Hanaire, Reinhard W. Holl, John R. Petrie, Anne L. Peters, Mark Evans

Diabetes Care 2022;45(12):3058–3074

DOI: https://doi.org/10.2337/dci22-0018

Published: 06 October 2022

View article

Journal Articles

Randomized, Controlled Trial of a Digital Behavioral Therapeutic Application to Improve Glycemic Control in Adults With Type 2 Diabetes

Judith Hsia, Nicole L. Guthrie, Paul Lupinacci, Ananda Gubbi, Douglas Denham, Mark A. Berman, Marc P. Bonaca

Diabetes Care 2022;45(12):2976–2981

DOI: https://doi.org/10.2337/dc22-1099

Published: 01 October 2022

View article

Journal Articles

7. Diabetes Technology: Standards of Medical Care in Diabetes—2022

American Diabetes Association Professional Practice Committee

Diabetes Care 2022;45(Supplement_1):S97–S112

DOI: https://doi.org/10.2337/dc22-S007

Published: 16 December 2021

View article

Journal Articles

Multicenter Trial of a Tubeless, On-Body Automated Insulin Delivery System With Customizable Glycemic Targets in Pediatric and Adult Participants With Type 1 Diabetes

Sue A. Brown, Gregory P. Forlenza, Bruce W. Bode, Jordan E. Pinsker, Carol J. Levy, Amy B. Criego, David W. Hansen, Irl B. Hirsch, Anders L. Carlson, Richard M. Bergenstal, Jennifer L. Sherr, Sanjeev N. Mehta, Lori M. Laffel, Viral N. Shah, Anuj Bhargava, Ruth S. Weinstock, Sarah A. MacLeish, Daniel J. DeSalvo, Thomas C. Jones, Grazia Aleppo, Bruce A. Buckingham, Trang T. Ly, Omnipod 5 Research Group, Sue A. Brown, Mary Voelmle, Emma Emory, Gregory P. Forlenza, R. Paul Wadwa, Robert Slover, Erin Cobry, Laurel H. Messer, Cari Berget, Susan McCoy, Viral N. Shah, Halis K. Akturk, Nicole Schneider, Hal Joseph, Prakriti Joshee, Christie Beatson, Bruce W. Bode, Brooke Narron, Tricia Lopez, Jordan E. Pinsker, Mei Mei Church, Kristin Castorino, Molly Piper, Jimena Perez, Carol J. Levy, David W. Lam, Camilla Levister, Grenye O’Malley, Selassie Ogyaadu, Dushyanthy Arasaratnam, Mitchell Plesser, Emily Nosova, Suzan Bzdick, David W. Hansen, Sheri L. Stone, Ruth S. Weinstock, Irl B. Hirsch, Subbulaxmi Trikudanathan, Nancy Sanborn, Dori Khakpour, Anders L. Carlson, Amy B. Criego, Richard M. Bergenstal, Thomas Martens, Aimee Grieme, Jamie Hyatt, Alina Punel, Diane Whipple, Jennifer L. Sherr, Michelle Van Name, Michelle Brei, Melinda Zgorski, Amy Steffen, Lori Carria, Sanjeev N. Mehta, Lori M. Laffel, Lindsay Roethke, Margaret Fisher, Rebecca Ortiz La Banca, Lisa Volkening, Louise Ambler-Osborn, Christine Turcotte, Emily F. Freiner, Anuj Bhargava, Lisa Borg, Sarah A. MacLeish, Jamie R. Wood, Beth A. Kaminski, Terri L. Casey, Wendy Campbell, Daniel J. DeSalvo, Siripoom McKay, Mary Kylie DeLaO, Carolina Villegas, Thomas C. Jones, Barry Russel Johns, Ashwini Gore, Leslie Harvill, Kayla Merritt, Jennifer Stanfield, Jennifer Sheldon, Lisa Hichkad, Erica Burnett, Alicia Castelot, Lindsay Bounds, Kaitlyn Preston, Rebecca Goldfaden, Grazia Aleppo, Jelena Kravarusic, Anupam Bansal, Bruce A. Buckingham, Laya Ekhlaspour, Ryan Kingman, Kaisa Kivilaid, Krista Kleve, Trang T. Ly, Bonnie Dumais, Todd Vienneau, Lauren M. Huyett, Joon Bok Lee, Jason O’Connor, Eric Benjamin

Diabetes Care 2021;44(7):1630–1640

DOI: https://doi.org/10.2337/dc21-0172

Published: 20 July 2021

View article

Journal Articles

Diabetes Technology Use for Management of Type 1 Diabetes Is Associated With Fewer Adverse COVID-19 Outcomes: Findings From the T1D Exchange COVID-19 Surveillance Registry

Nudrat Noor, Osagie Ebekozien, Laura Levin, Sheri Stone, David P. Sparling, Robert Rapaport, David M. Maahs

Diabetes Care 2021;44(8):e160–e162

DOI: https://doi.org/10.2337/dc21-0074

Published: 18 June 2021

View article

Journal Articles

7. Diabetes Technology: Standards of Medical Care in Diabetes—2021

American Diabetes Association

Diabetes Care 2021;44(Supplement_1):S85–S99

DOI: https://doi.org/10.2337/dc21-S007

Published: 04 December 2020

View article

Journal Articles

Sedentary Time and Metabolic Risk in Extremely Active Older Adults

Kenneth M. Madden, Boris Feldman, Jocelyn Chase

Diabetes Care 2021;44(1):194–200

DOI: https://doi.org/10.2337/dc20-0849

Published: 16 October 2020

View article

Journal Articles

Six Months of Hybrid Closed-Loop Versus Manual Insulin Delivery With Fingerprick Blood Glucose Monitoring in Adults With Type 1 Diabetes: A Randomized, Controlled Trial

Sybil A. McAuley, Melissa H. Lee, Barbora Paldus, Sara Vogrin, Martin I. de Bock, Mary B. Abraham, Leon A. Bach, Morton G. Burt, Neale D. Cohen, Peter G. Colman, Elizabeth A. Davis, Christel Hendrieckx, D. Jane Holmes-Walker, Joey Kaye, Anthony C. Keech, Kavita Kumareswaran, Richard J. MacIsaac, Roland W. McCallum, Catriona M. Sims, Jane Speight, Stephen N. Stranks, Vijaya Sundararajan, Steven Trawley, Glenn M. Ward, Alicia J. Jenkins, Timothy W. Jones, David N. O’Neal, Australian JDRF Closed-Loop Research Group, David N. O’Neal, Sybil A. McAuley, Melissa H. Lee, Barbora Paldus, Catriona M. Sims, Richard J. MacIsaac, Glenn M. Ward, Peter G. Colman, Neale D. Cohen, Leon A. Bach, Kavita Kumareswaran, Stephen N. Stranks, Morton G. Burt, D. Jane Holmes-Walker, Roland W. McCallum, Joey Kaye, Jane Speight, Christel Hendrieckx, Jennifer Halliday, Sienna Russell-Green, Steven Trawley, Alicia J. Jenkins, Andrzej Januszewski, Anthony C. Keech, Sara Vogrin, Vijaya Sundararajan, Hanafi Mohammed Husin, Philip M. Clarke, Timothy W. Jones, Elizabeth A. Davis, Martin I. de Bock, Mary B. Abraham, Geoff R. Ambler, Fergus J. Cameron, Jan M. Fairchild, Bruce R. King

Diabetes Care 2020;43(12):3024–3033

DOI: https://doi.org/10.2337/dc20-1447

Published: 14 October 2020

View article

Journal Articles

Glycemic Outcomes of Use of CLC Versus PLGS in Type 1 Diabetes: A Randomized Controlled Trial

Sue A. Brown, Roy W. Beck, Dan Raghinaru, Bruce A. Buckingham, Lori M. Laffel, R. Paul Wadwa, Yogish C. Kudva, Carol J. Levy, Jordan E. Pinsker, Eyal Dassau, Francis J. Doyle, III, Louise Ambler-Osborn, Stacey M. Anderson, Mei Mei Church, Laya Ekhlaspour, Gregory P. Forlenza, Camilla Levister, Vinaya Simha, Marc D. Breton, Craig Kollman, John W. Lum, Boris P. Kovatchev, iDCL Trial Research Group, Boris Kovatchev, Stacey Anderson, Emma Emory, Mary Voelmle, Katie Conshafter, Kim Morris, Mary Oliveri, Linda Gondor-Fredrick, Harry Mitchell, Kayla Calvo, Christian Wakeman, Marc Breton, Lori Laffel, Elvira Isganaitis, Louise Ambler-Osborn, Emily Flint, Kenny Kim, Lindsay Roethke, Jordan Pinsker, Mei Mei Church, Camille Andre, Molly Piper, Carol Levy, David Lam, Grenye O’Malley, Camilla Levister, Selassie Ogyaadu, Jessica Lovett, Yogish C. Kudva, Vinaya Simha, Vikash Dadlani, Shelly McCrady-Spitzer, Corey Reid, Kanchan Kumari, R. Paul Wadwa, Greg Forlenza, G. Todd Alonso, Robert Slover, Emily Jost, Laurel Messer, Cari Berget, Lindsey Towers, Alex Rossick-Solis, Bruce Buckingham, Laya Ekhlaspour, Tali Jacobson, Marissa Town, Ideen Tabatabai, Jordan Keller, Evalina Salas, Francis Doyle, III, Eyal Dassau, John Lum, Roy Beck, Samantha Passman, Tiffany Campos, Dan Raghinaru, Craig Kollman, Carlos Murphy, Nandan Patibandla, Sarah Borgman, Guillermo Arreza-Rubin, Thomas Eggerman, Neal Green, Boris Kovatchev, Sue Brown, Stacey Anderson, Marc Breton, Lori Laffel, Jordan Pinsker, Carol Levy, Yogish C. Kudva, R. Paul Wadwa, Bruce Buckingham, Francis Doyle III, Eric Renard, Claudio Cobelli, Yves Reznik, Guillermo Arreza-Rubin, John Lum, Roy Beck, Robert Janicek, Deanna Gabrielson, Steven H. Belle, Jessica Castle, Jennifer Green, Laurent Legault, Steven M. Willi, Carol Wysham, Thomas Eggerman

Diabetes Care 2020;43(8):1822–1828

DOI: https://doi.org/10.2337/dc20-0124

Published: 29 May 2020

View article

Journal Articles

Quality of Life and Glucose Control After 1 Year of Nationwide Reimbursement of Intermittently Scanned Continuous Glucose Monitoring in Adults Living With Type 1 Diabetes (FUTURE): A Prospective Observational Real-World Cohort Study

Sara Charleer, Christophe De Block, Liesbeth Van Huffel, Ben Broos, Steffen Fieuws, Frank Nobels, Chantal Mathieu, Pieter Gillard

Diabetes Care 2020;43(2):389–397

DOI: https://doi.org/10.2337/dc19-1610

Published: 16 December 2019

View article

Includes: Supplementary data

Journal Articles

7. Diabetes Technology: Standards of Medical Care in Diabetes—2020

American Diabetes Association

Diabetes Care 2020;43(Supplement_1):S77–S88

DOI: https://doi.org/10.2337/dc20-S007

Published: 16 December 2019

View article

Journal Articles

Diabetes Digital App Technology: Benefits, Challenges, and Recommendations. A Consensus Report by the European Association for the Study of Diabetes (EASD) and the American Diabetes Association (ADA) Diabetes Technology Working Group

G. Alexander Fleming, John R. Petrie, Richard M. Bergenstal, Reinhard W. Holl, Anne L. Peters, Lutz Heinemann

Diabetes Care 2020;43(1):250–260

DOI: https://doi.org/10.2337/dci19-0062

Published: 12 December 2019

View article

Journal Articles

One Year Clinical Experience of the First Commercial Hybrid Closed-Loop System

Rayhan A. Lal, Marina Basina, David M. Maahs, Korey Hood, Bruce Buckingham, Darrell M. Wilson

Diabetes Care 2019;42(12):2190–2196

DOI: https://doi.org/10.2337/dc19-0855

Published: 23 September 2019

View article

Includes: Supplementary data

Journal Articles

Diagnostic Accuracy of a Device for the Automated Detection of Diabetic Retinopathy in a Primary Care Setting

Frank D. Verbraak, Michael D. Abramoff, Gonny C.F. Bausch, Caroline Klaver, Giel Nijpels, Reinier O. Schlingemann, Amber A. van der Heijden

Diabetes Care 2019;42(4):651–656

DOI: https://doi.org/10.2337/dc18-0148

Published: 14 February 2019

View article

Includes: Supplementary data

Journal Articles

7. Diabetes Technology: Standards of Medical Care in Diabetes—2019

American Diabetes Association

Diabetes Care 2019;42(Supplement_1):S71–S80

DOI: https://doi.org/10.2337/dc19-S007

Published: 07 December 2018

View article

Journal Articles

Clinical Impact of ITCA 650, a Novel Drug-Device GLP-1 Receptor Agonist, in Uncontrolled Type 2 Diabetes and Very High Baseline HbA_1c: The FREEDOM-1 HBL (High Baseline) Study

Robert R. Henry, Julio Rosenstock, Douglas S. Denham, Prakash Prabhakar, Lise Kjems, Michelle A. Baron

Diabetes Care 2018;41(3):613–619

DOI: https://doi.org/10.2337/dc17-1519

Published: 04 January 2018

View article

Includes: Supplementary data

2 3 4

NARROW

Safety and Efficacy of the Omnipod 5 Automated Insulin Delivery System in Adults With Type 2 Diabetes: From Injections to Hybrid Closed-Loop Therapy

Quantifying the Relationship Between Physical Activity Energy Expenditure and Incident Type 2 Diabetes: A Prospective Cohort Study of Device-Measured Activity in 90,096 Adults

7. Diabetes Technology: Standards of Care in Diabetes—2023

Index

Automated Insulin Delivery: Benefits, Challenges, and Recommendations. A Consensus Report of the Joint Diabetes Technology Working Group of the European Association for the Study of Diabetes and the American Diabetes Association

Randomized, Controlled Trial of a Digital Behavioral Therapeutic Application to Improve Glycemic Control in Adults With Type 2 Diabetes

7. Diabetes Technology: Standards of Medical Care in Diabetes—2022

Multicenter Trial of a Tubeless, On-Body Automated Insulin Delivery System With Customizable Glycemic Targets in Pediatric and Adult Participants With Type 1 Diabetes

Diabetes Technology Use for Management of Type 1 Diabetes Is Associated With Fewer Adverse COVID-19 Outcomes: Findings From the T1D Exchange COVID-19 Surveillance Registry

7. Diabetes Technology: Standards of Medical Care in Diabetes—2021

Sedentary Time and Metabolic Risk in Extremely Active Older Adults

Six Months of Hybrid Closed-Loop Versus Manual Insulin Delivery With Fingerprick Blood Glucose Monitoring in Adults With Type 1 Diabetes: A Randomized, Controlled Trial

Glycemic Outcomes of Use of CLC Versus PLGS in Type 1 Diabetes: A Randomized Controlled Trial

Quality of Life and Glucose Control After 1 Year of Nationwide Reimbursement of Intermittently Scanned Continuous Glucose Monitoring in Adults Living With Type 1 Diabetes (FUTURE): A Prospective Observational Real-World Cohort Study

7. Diabetes Technology: Standards of Medical Care in Diabetes—2020

Diabetes Digital App Technology: Benefits, Challenges, and Recommendations. A Consensus Report by the European Association for the Study of Diabetes (EASD) and the American Diabetes Association (ADA) Diabetes Technology Working Group

One Year Clinical Experience of the First Commercial Hybrid Closed-Loop System

Diagnostic Accuracy of a Device for the Automated Detection of Diabetic Retinopathy in a Primary Care Setting

7. Diabetes Technology: Standards of Medical Care in Diabetes—2019

Clinical Impact of ITCA 650, a Novel Drug-Device GLP-1 Receptor Agonist, in Uncontrolled Type 2 Diabetes and Very High Baseline HbA_1c: The FREEDOM-1 HBL (High Baseline) Study

Email alerts

Journals

Books

Clinical Compendia

News

Other

About

Resources

Email alerts

Journals

Books

Clinical Compendia

News

Other

About

Resources

This Feature Is Available To Subscribers Only